Evidence map›Paper›PMID 39833465›Full record

ArticleCellular and molecular life sciences : CMLS2025

N

Zhihui Bai, Qianlin Xia, Wanli Xu, Zhirong Wu, Xiaomeng He, Xin Zhang, Zhefeng Wang, Mengting Luo, Huaqin Sun, Songmei Liu and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Zhihui Bai *Central Laboratory, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, 361015, China.
Qianlin Xia *Laboratory Medicine, Shanghai Sixth People's Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.
Wanli XuCentral Laboratory, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, 361015, China.
Zhirong WuDepartment of General Surgery, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, 361015, China.
Xiaomeng HeShanghai Public Health Clinical Center, Fudan University, 2901 Caolang Road, Jinshan District, Shanghai, China.
Xin ZhangCentral Laboratory, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, 361015, China.
Zhefeng WangXiamen Key Laboratory of Biotherapy, Xiamen, 361015, China.
Mengting LuoCentral Laboratory, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, 361015, China.
Huaqin SunCentral Laboratory, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, 361015, China.
Songmei LiuDepartment of Clinical Laboratory, Center for Gene Diagnosis & Program of Clinical Laboratory, Zhongnan Hospital of Wuhan University, Wuhan, China.
Jin WangCentral Laboratory, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, 361015, China. wang.jin@zsxmhospital.com.ORCID http://orcid.org/0000-0002-0062-2489

Funding

Natural Science Foundation of Fujian Province 2024J011432
6 · The paper itself

Abstract

Emerging evidence has shown that the N

Indexed as

AdenosineBiomarkers, TumorImmunotherapyPancreatic NeoplasmsRNA, Long NoncodingGene Expression Regulation, NeoplasticHumansPrognosisTumor MicroenvironmentAdenosineBiomarkers, TumorN-methyladenosineRNA, Long NoncodingImmunotherapylncRNAm6APancreatic cancerPrognosis

Identifiers

PMID39833465
PMCPMC11753445

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.